|
||
|---|---|---|
|
2 quality improvement measures receive national endorsement Many hospitalized patients with community-acquired pneumonia or urinary tract infections receive unnecessary antibiotics, which can lead to adverse events, such as C. difficile infection, antibiotic resistance and delays in diagnosing underlying conditions. The Michigan Hospital Medicine Safety Consortium, one of Blue Cross Blue Shield of Michigan’s Collaborative Quality Initiatives, recently earned endorsements from the National Quality Forum* for two HMS-developed quality improvement measures focused on reducing unnecessary antibiotic use for the following common and costly situations:
“HMS is a collaborative focused on improving the quality of care for hospitalized medical patients throughout the state of Michigan,” said Scott Flanders, M.D., HMS program director and chief clinical strategy officer for Michigan Medicine. “We’re incredibly proud of the work our collaborative has accomplished. Having two of our quality measures validated by the National Quality Forum reinforces the value of our work in Michigan and across the nation.” The NQF uses a rigorous evaluation process, led by expert multidisciplinary committees, to grant select endorsements that are intended to help health care providers make choices based on thoroughly vetted, consistent and credible measures. “We applaud HMS and its statewide consortium of Michigan hospitals for tackling this important issue and receiving NQF recognition as a result,” said Amy McKenzie, M.D., vice president, Clinical Partnerships, and associate chief medical officer. To learn more about HMS and the other CQIs, visit the Collaborative Quality Initiatives section of valuepartnerships.com. |
*Blue Cross Blue Shield of Michigan doesn’t own or control this website. |